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Summary
Aims
To study an asymptomatic group of HIV positive men
on antiretroviral drugs and compare them to age and
sex matched controls in order to detect underlying car-
diovascular disease.
Background
The increased survival associated with the advent of
antiretroviral therapy (ART) for HIV in the mid-1990s
has been accompanied by an increase in cardiovascular
comorbidity and mortality. Atherothrombosis, myocar-
dial disease, hypertension, diabetes, and pulmonary
hypertension have been identified as entities associated
with treated disease and the risk of major cardiovascular
events is higher than in the uninfected population. HIV
patients on ART are at higher risk of developing left
ventricular (LV) systolic dysfunction, and more recent
studies have additionally demonstrated significantly
higher levels of diastolic dysfunction and LV hypertro-
phy to controls.
Methods
Methods: Prospective cohort study of asymptomatic
HIV positive men on antiretroviral drugs. Baseline
demographics, routine biochemistry, fasting lipids and
glucose were recorded. A resting 12 lead ECG was taken
on all participants. Patients were scanned on a 3T Phi-
lips machine with standard protocols as per SCMR
guidelines and received weight based intravenous gadoli-
nium. Controls were age and sex matched. Post analysis
software was used for LV function, mass and wall thick-
ness. Diastolic function was assessed using phase con-
trast analysis of mitral inflow to calculate e:a ratio.
Results
30 HIV positive men were compared with 13 male
healthy controls. Mean age for cases vs controls was
50.3 years (+/-9years) vs 41.7 (+/- 6.5 years) respectively.
Established cardiovascular risk was prevalent in the HIV
population at higher rates than controls: cigarette smok-
ing 35%, hypertension on treatment 29.4%, hyperlipidae-
mia 44.1% with 29.4% on statin therapy vs 0% of
controls who smoked, had hypertension or were on sta-
tin treatment. HIV patients had a higher rate of diastolic
dysfunction, had greater prevalence of increased wall
thickness and had more abnormalities detected, both
cardiac and non-cardiac(see table 1).
Conclusions
In this asymptomatic population of HIV positive men
we found an increased incidence of silent myocardial
infarction and increased wall thickness. There was also
an increase in diastolic dysfunction compared to age
matched controls. These data will be expanded to
further investigate whether these findings are due to the
effects of long term antiretroviral therapy or as a result
of increased prevalence of established cardiovascular
risks in this patient cohort.
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Table 1 MR Findings
Cases Controls P value
LVEF(%+/-SD) 66.2 (+/-6 ) 63.9 (+/-7 ) 0.31
LMVI(g/m2+/-SD) 59.84(+/- 12.99) 53.24 (+/-14) 0.136
Diastolic dysfunction (no, %) 12(35%) 0(0%) 0.0001
Anteroseptal Wall Thickness(mm+/-SD) 11.22(+/-2) 8.93(+/-2.34) 0.007
Posterolateral Wall Thickness(mm+/-SD) 8.18(+/-1.47) 8.56(+/-1.46) 0.45
Presence of Late Gad enhancement in infarct pattern. No.(%) 2(6%) 0 0.16
Extracardiac Findings Pericardial cyst Thymoma 0
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